Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Higher androgen levels do not cause baldness in men.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

The normal human prostate does not significantly affect blood DHT levels.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.